Author Affiliations: Harvard Clinical Research Institute, Harvard Medical School, Boston, Massachusetts (Drs Novack and Cutlip); Soroka Clinical Research Center, Beer Sheva, Israel (Dr Novack); St Luke's Mid America Heart Institute, Kansas City, Missouri (Dr Cohen); and Beth Israel Deaconess Medical Center, Boston (Dr Cutlip).
We read with interest the Invited Commentary by Drs Alpert and Jaffe1 on our article “Troponin Criteria for Myocardial Infarction After Percutaneous Coronary Intervention.”2 Although they make several excellent points and we agree with many of their assertions, we believe that several issues that they have raised warrant comment.
Novack V, Cohen DJ, Cutlip DE. Misconstrued Intentions: Setting the Record Straight. Arch Intern Med. 2012;172(18):1425-1427. doi:10.1001/archinternmed.2012.3752